September 19, 2022 by Chain Drug Review
Brian Tyler, McKesson Corporation, Rx Savings Solutions
Business, Featured Articles, Leading Headlines, Pharmacy

OVERLAND PARK, Kan. — McKesson Corp. announced on Monday that it has signed a definitive agreement to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers, reaching more than 17 million current patients. The transaction is valued up to $875 million,
August 19, 2020 by Chain Drug Review
Brian Tyler, iversity Best Practices (DBP) fourth annual Inclusion Index, McKesson Corp.
Featured Articles, Leading Headlines, Pharmacy

IRVING, Texas — McKesson announced that it has been named to the Diversity Best Practices (DBP) fourth annual Inclusion Index. McKesson was among the 98 organizations that earned a top score and a place on the index. “McKesson is creating a better future through our collective commitment to move beyond unconscious bias and embrace conscious
August 17, 2020 by Chain Drug Review
Brian Tyler, COVID-19, McKesson Corp., Operation Warp Speed (OWS)
Leading Headlines, Pharmacy

IRVING, Texas — McKesson Corp. announced that it will expand its existing partnership with the Centers for Disease Control (CDC) to support the U.S. government’s Operation Warp Speed (OWS) team as a centralized distributor of future COVID-19 vaccines and ancillary supplies needed to administer vaccinations. Vaccines and related supplies will be delivered to point-of-care sites
August 10, 2020 by Chain Drug Review
Brian Tyler, Domenic Pilla, McKesson Canada, Rebecca McKillican
Leading Headlines, Pharmacy, Retail News

IRVING, Texas — McKesson Corp. announced on Monday the appointment of Rebecca McKillican as chief executive officer, McKesson Canada effective immediately. McKillican succeeds Domenic Pilla, who announced his plans to retire from the company in late 2019. As CEO, McKillican is responsible for leading McKesson’s portfolio of businesses in Canada including pharmaceutical distribution operations, McKesson
July 20, 2020 by Chain Drug Review
2020 Best Places to Work for Disability Inclusion, Brian Tyler, McKesson, The Disability Equality Index (DEI)
Leading Headlines, Pharmacy

IRVING, Texas — McKesson recently announced that The Disability Equality Index (DEI) has named the company as one of its 2020 Best Places to Work for Disability Inclusion with a top-ranking score of 100. This is the fifth year in a row that McKesson has been recognized by the DEI as a top place to
July 3, 2020 by Chain Drug Review
Brian Tyler, Kirk Kaminsky, McKesson
Business, Leading Headlines, Pharmacy

IRVING, Texas— McKesson Corp. announced changes to its reportable business structure. The company has revised its reportable segments commencing in the second quarter of fiscal 2021. These moves reflect the company’s continued focus on delivering new and innovative solutions to respond to the evolving needs of the healthcare industry, customers and patients. “McKesson has had
June 9, 2020 by Chain Drug Review
Brian Tyler, Dave Schulte, McKesson Corp., Tom Rodgers
Business, Leading Headlines

IRVING, Texas – McKesson Corp. recently announced that Tom Rodgers has been appointed executive vice president and chief strategy and business development officer effective June 5th. In his new role, Rodgers will also become a member of the company’s executive operating team. Rodgers succeeds Bansi Nagji who stepped down from his role effective March 31,
May 20, 2020 by Chain Drug Review
Brian Tyler, Change Healthcare, McKesson Corp.
Business, Leading Headlines

IRVING, Texas — McKesson Corp. reported results on Wednesday for the fourth quarter and fiscal year that ended March 31, 2020. “McKesson delivered a strong finish to fiscal 2020, reflecting continued momentum in the business and meaningful progress in our transformation towards becoming a more focused organization as we look to capture future growth opportunities,”
March 24, 2020 by Chain Drug Review
Bansi Nagji, Brian Tyler, McKesson Corp.
Business, Leading Headlines, Supplier News

IRVING, Texas — McKesson Corp. announced Tuesday that Bansi Nagji, executive vice president and chief strategy and business development officer, will step down from his role effective March 31, 2020. Nagji has agreed to continue employment with the company for several weeks to assist with transition activities. McKesson is currently conducting a comprehensive search and
July 8, 2019 by Jeffrey Woldt
Brian Tyler, John Hammergren, McKesson
July 8, 2019, News

IRVING, Texas — A week before he succeeded John Hammergren as chief executive officer of McKesson Corp., Brian Tyler wrote on the company’s website that he was getting ready for the job of a lifetime. Tyler might have added that, in light of the serious problems that continue to plague the health care system in
December 19, 2018 by Chain Drug Review
Brian Tyler, harmaceutical sourcing and distribution partnership, John Standley, McKesson Corp., Rite Aid Corp.
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

CAMP HILL, Pa. – Rite Aid Corp. and McKesson Corp. announced an agreement to key terms that will continue the companies’ pharmaceutical sourcing and distribution partnership for an additional 10 years. Under these terms, McKesson will continue providing Rite Aid with sourcing and direct-to-store delivery for brand and generic pharmaceutical products through March 2029. Rite
December 3, 2018 by Chain Drug Review
Brian Tyler, John Hammergren, Las Colinas, McKesson Corp.
Business, Leading Headlines, Pharmacy

SAN FRANCISCO — McKesson Corp. has announced the relocation of its corporate headquarters from San Francisco, Calif. to Las Colinas, Texas, effective April 1, 2019, expanding upon its presence in the Dallas area. “We are excited to strengthen our presence in Texas and make Las Colinas our official global headquarters,” said John Hammergren, chairman and chief
November 1, 2018 by Chain Drug Review
Brian Tyler, Edward Mueller, John Hammergren, McKesson Corp.
Featured Articles, Leading Headlines, Pharmacy, Retail News

SAN FRANCISCO — McKesson Corp. announced that John Hammergren, chairman and chief executive officer, has decided to retire, effective March 31, 2019. McKesson’s board of directors has unanimously selected Brian Tyler, currently president and chief operating officer, to succeed Hammergren as CEO, effective April 1, 2019. Tyler will also remain as president. Edward Mueller, currently
October 23, 2018 by Chain Drug Review
Brian Tyler, McKesson Corp., McKesson Life Sciences
Featured Articles, Leading Headlines, Pharmacy

THE WOODLANDS, Texas — McKesson Corp. announced that it has relaunched its biopharmaceutical services business under its U.S. Pharmaceutical and Specialty Health business unit as McKesson Life Sciences. The new structure not only reflects its continued dedication to serving the life sciences industry, but also indicates how the business has evolved to meet the industry’s need